A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

Name: A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil
SKU: 8007
Availability: InStock

$0.00

A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

By Robert Risinger, Marjie Hard, Peter J. Weiden

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Psychopharmacology Bulletin, VOL 47 No. 3 Articles - 2017 Tags: antipsychotic-agents, aripiprazole, aripiprazole-lauroxil, marjie-hard, peter-j-weiden, prodrugs, psychomotor-agitation, psychopharmacology, robert-risinger, schizophrenia, weight-gain

Description

Description

A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

By Robert Risinger, Marjie Hard, Peter J. Weiden

26-34_PB-47-3-2017_Risinger

A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

Description

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Gender and Schizophrenia

Schizophrenia and Valproate

A Phase-1 Study Comparing Pharmacokinetic and Safety Profiles of Three Different Dose Intervals of Aripiprazole Lauroxil

Description

Related products

Schizophrenia Rating Scales Critical Review by Takefumi Suzuki

Agomelatine for Depression in Schizophrenia by Jochen Mutschler

Gender and Schizophrenia

Schizophrenia and Valproate